CR Pharma SRL
CR Pharma reported total assets of €2.16m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 May 2026).
The score of CR Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1548 % Total assets +2882 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CR Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 May 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 21 Jun 2023
CR Pharma's financial analysis
- Solvency37.7%sector median: 54.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CR Pharma
CR Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0779.890.292
- VAT number
- BE0779890292
- Peppol
- Registered · 0208:0779890292 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jan 2022
- Registered office
- 8530 Harelbeke
- Latest accounts
- 2025 · filed on 22 May 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
CR Pharma (SRL) has been based in Harelbeke since 2022, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 189,849 € and equity of 812,986 €; its revenue is not published. Its solvency stands at 37.7%, below the median of its sector (54.9%).
Companies similar to CR Pharma
Companies in the same business, of comparable size and area, outside its group.
- Strybol Wout Pharma Other business support service activities n.e.c. Bruges · balance sheet €2.17m
- Ares4S Other business support service activities n.e.c. Nijlen · balance sheet €2.17m
- Jogi Invest Other business support service activities n.e.c. Denderleeuw · balance sheet €2.14m
- Beton Brut Other business support service activities n.e.c. Ghent · balance sheet €2.13m
- Belart & CO Other business support service activities n.e.c. Wavre · balance sheet €2.13m
- Brawo Other business support service activities n.e.c. Sint-Laureins · balance sheet €2.11m
- Aligno Other business support service activities n.e.c. Mol · balance sheet €2.21m
- Vincent De Moor Other business support service activities n.e.c. Antwerp · balance sheet €2.23m
Frequently asked questions about CR Pharma
What is the revenue of CR Pharma?
CR Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CR Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0779890292 for CR Pharma, if the company is VAT-registered. Its company number (CBE) is 0779.890.292.
Where is the registered office of CR Pharma?
According to the CBE register, the registered office of CR Pharma is in 8530 Harelbeke.
What is the equity of CR Pharma?
At the close of the 2025 financial year, the equity of CR Pharma amounts to 812,986 €, a solvency of 37.7% of total assets.
Who manages CR Pharma?
The register lists 1 active mandates at CR Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CR Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →